Mechanisms of action of isothiocyanates in cancer chemoprevention: an update

被引:91
|
作者
Navarro, Sandi L. [1 ,2 ]
Li, Fei [1 ]
Lampe, Johanna W. [1 ,2 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA
[2] Univ Washington, Interdisciplinary Grad Program Nutr Sci, Dept Epidemiol, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
NF-KAPPA-B; CELL-CYCLE ARREST; HISTONE DEACETYLASE INHIBITORS; S-TRANSFERASE POLYMORPHISMS; CRUCIFEROUS VEGETABLES; PROSTATE-CANCER; PHENETHYL ISOTHIOCYANATE; ALLYL-ISOTHIOCYANATE; DIETARY ISOTHIOCYANATES; BREAST-CANCER;
D O I
10.1039/c1fo10114e
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Isothiocyanates (ITC), derived from glucosinolates, are thought to be responsible for the chemoprotective actions conferred by higher cruciferous vegetable intake. Evidence suggests that isothiocyanates exert their effects through a variety of distinct but interconnected signaling pathways important for inhibiting carcinogenesis, including those involved in detoxification, inflammation, apoptosis, and cell cycle and epigenetic regulation, among others. This article provides an update on the latest research on isothiocyanates and these mechanisms, and points out remaining gaps in our understanding of these events. Given the variety of ITC produced from glucosinolates, and the diverse pathways on which these compounds act, a systems biology approach, in vivo, may help to better characterize their integrated role in cancer prevention. In addition, the effects of dose, duration of exposure, and specificity of different ITC should be considered.
引用
收藏
页码:579 / 587
页数:9
相关论文
共 50 条
  • [41] Natural isothiocyanates: Genotoxic potential versus chemoprevention
    Fimognari, Carmela
    Turrini, Eleonora
    Ferruzzi, Lorenzo
    Lenzi, Monia
    Hrelia, Patrizia
    MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2012, 750 (02) : 107 - 131
  • [42] Chemoprevention by Isothiocyanates: Molecular Basis of Apoptosis Induction
    Nakamura, Yoshimasa
    FOOD FACTORS FOR HEALTH PROMOTION, 2009, 61 : 170 - 181
  • [43] Exploring Chemoprevention in Colorectal Cancer for Patients with Inflammatory Bowel Disease: Mechanisms of Action and Clinical Aspects
    Fousekis, Fotios S.
    Mpakogiannis, Konstantinos
    Filis, Panagiotis
    Skamnelos, Alexandros
    Christodoulou, Dimitrios K.
    Mauri, Davide
    Katsanos, Konstantinos H.
    CANCERS, 2025, 17 (02)
  • [44] Update on the use of oral iloprost for the chemoprevention of lung cancer
    Keith, Robert L.
    Jackson, Mary K.
    Meisinger, Vicki
    Miller, York E.
    Franklin, Wilbur A.
    Hirsch, Fred
    Kittelson, John
    Merrick, Daniel
    Kelly, Karen
    Bunn, Paul A.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S330 - S331
  • [45] Update from Asia - Asian studies on cancer chemoprevention
    Yun, TK
    CANCER PREVENTION: NOVEL NUTRIENT AND PHARMACEUTICAL DEVELOPMENTS, 1999, 889 : 157 - 192
  • [46] Chemoprevention and Treatment of Pancreatic Cancer: Update and Review of the Literature
    Benzel, Julia
    Fendrich, Volker
    DIGESTION, 2018, 97 (04) : 275 - 287
  • [47] TAMOXIFENS ROLE IN CHEMOPREVENTION OF BREAST-CANCER - AN UPDATE
    NAYFIELD, SG
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 42 - 50
  • [48] Targeting epigenetic regulatory mechanisms in cancer chemoprevention
    Fay, JR
    Crowell, JA
    Kopelovich, L
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2005, 9 (02) : 315 - 328
  • [49] Molecular mechanisms of chemoprevention and therapy of cancer by retinoids
    Shen, PF
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 : 2663 - 2670
  • [50] Mechanisms of mammary cancer chemoprevention by organoselenium compounds
    El-Bayoumy, K
    Sinha, R
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2004, 551 (1-2) : 181 - 197